Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus: Alterations in hyperammonemia

Neurochemistry International

Volumn 45, Issue 6, 2004, Pages 895-901

  Monfort, Pilar ^a   Muñoz, María Dolores ^b   Kosenko, Elena ^a   Llansola, Marta ^a   Sánchez Pérez, Ana ^a   Cauli, Omar ^a   Felipo, Vicente ^a  

^a Laboratorio de Neurobiologia de Prince Felipe Research Centre   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

cGMP; Long term potentiation; Phosphodiesterase; Soluble guanylate cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; AMMONIA; CALPHOSTIN C; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE; PROTEIN KINASE C INHIBITOR; ZAPRINAST;

BRAIN SLICE; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; HUMAN; HYPERAMMONEMIA; LEARNING; LIVER DISEASE; LONG TERM POTENTIATION; MEMORY; MENTAL DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TETANUS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ELECTRIC STIMULATION; ENZYME ACTIVATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GUANYLATE CYCLASE; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; HUMANS; HYPERAMMONEMIA; LONG-TERM POTENTIATION; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 4243115018     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.020     Document Type: Conference Paper

References (37)

1. Aguilar M.A., Miñarro J., Felipo V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp. Neurol. 161:2000;704-713
2. Akers R.F., Lovinger D.M., Colley P.A., Linden D.J., Routtenberg A. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science. 231:1986;587-589
3. Arancio O., Antonova I., Gambaryan S., Lohmann S.M., Wood J.S., Lawrence D.S., Hawkins R.D. Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J. Neurosci. 21:2001;143-149
4. Blitzer R.D., Wong T., Nouranifar R., Iyengar R., Landau E.M. Postsynapyic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron. 15:1995;1403-1414
5. Böhme G.A., Bon C., Stutzmann J.M., Doble A., Blanchard J.C. Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol. 199:1991;379-381
6. Boulton C.L., Southam E., Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience. 69:1995;699-703
7. Breen, K.J., Schenker, S., 1972. Hepatic coma: present concept of pathogenesis and therapy. In: Poper, H., Schaffner, F. (Eds.), Prognosis in Liver Disease. Grune & Strattonn, New York, pp. 301-332.
8. Clemmesen J.O., Larsen F.S., Kondrup J., Hansen B.A., Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 29:1999;648-653
9. Chetkovich D.M., Klann E., Sweatt J.D. Nitric oxide synthase-independent long-term potentiation in area CA1 of hippocampus. Neuroreport. 4:1993;919-922
10. Corbin J.D., Turko I.V., Beasley A., Francis S.H. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem. 267:2000;2760-2767
11. Doyle C., Hölscher C., Rowan M.J., Anwyl R. The selective neuronal NO synthase inhibitor 7-nitroindazole blocks both long-term potentiation and depotentiation of field EPSPs in rat hippocampal CA1 in vivo. J. Neurosci. 16:1996;418-424
12. Duffiy, T.E., Plum, F., 1982. Hepatic encephalopathy. In: Arias, I., Popper, H., Schachter, D., Shafritz, D.A. (Eds.), The Liver: Biology and Pathobiology. Raven Press, New York, pp. 693-715.
13. Haley J.E., Malen P.L., Chapman P.F. Nitric oxide synthase inhibitors block long term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices. Neurosci. Lett. 160:1993;85-88
14. Hermenegildo C., Montoliu C., Llansola M., Muñoz M.D., Gaztelu J.M., Miñana M.D., Felipo V. Chronic hyperammonemia impairs the glutamate-nitricoxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10:1998;3201-3209
15. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 579:2002;1-21
16. Hu G.Y., Hvalby O., Walaas S.I., Albert K.A., Skjeflo P., Andersen P., Greengard P. Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation. Nature. 328:1987;426-429
17. Louis J.C., Revel M.O., Zwiller J. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim. Biophys. Acta. 1177:1993;299-306
18. López-Molina L., Boddeke H., Muller D. Blockade of long-term potentiation and of NMDA receptors by the protein kinase C antagonist calphostin C. Arch. Pharmacol. 348:1993;1-6
19. Lovinger D.M., Wong K.L., Murakami K., Routtenberg A. Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Brain Res. 436:1987;177-183
20. Lu Y., Kandel E.R., Hawkins R.D. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J. Neurosci. 19:1999;10250-10261
21. Lu W.Y., Man H., Ju W., Trimble W., MacDonald J.F., Wang Y. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron. 29:2001;243-254
22. Monfort P., Muñoz D., Kosenko E., Felipo V. Long- Term Potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J. Neurosci. 22:2002;10116-10122
23. Monfort P., Muñoz M.D., Felipo V. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G. Neurobiol. Dis. 15:2004;1-10
24. Msall M., Batshaw M.L., Suss R., Brusilow S.W., Mellitis E.D. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea cycle enzymopathies. N. Eng. J. Med. 310:1984;1500-1505
25. Muñoz D., Monfort P., Felipo V. Hyperammonemia impairs NMDA receptor-dependent long-term-potentiation in the CA1 of rat hippocampus in vitro. Neurochem. Res. 25:2000;437-441
26. O'Dell T.J., Hawkins R.D., Kandel E.R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11285-11289
27. Plum F. The CSF in hepatic encephalopathy. Exp. Biol. Med. 4:1971;34-41
28. Schuman E.M., Madison D.V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 254:1991;503-1506
29. Schuman E.M., Meffert M.K., Schulman H., Madison D.V. An ADP-ribosyl transferase as a potential target for nitric oxide action in hippocampal long-term potentiation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11958-11962
30. Selig D.K., Segal M.R., Liao D., Malenka R., Malinow R., Nicoll R.A., Lisman J.E. Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus. Learn. Memory. 3:1996;42-48
31. Shih, V.E., 1978. Urea cycle disorders and other congenital hyperammonemic syndromes. In: The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, pp. 362-386.
32. Thomas M.K., Francis S.H., Corbin J.D. Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP. J. Biol. Chem. 265:1990;14971-14978
33. Wu J., Wang Y., Rowan M.J., Anwy L.R. Evidence for involvement of the cGMP-protein kinase G signaling system in the induction of long term depression, but not long-term potentiation, in the dentate gyrus in vitro. J. Neurosci. 18:1998;3589-3596
34. Wyatt T.A., Naftilan A.J., Francis S.H., Corbin J.D. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274:1998;448-455
35. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639
36. Zwiller J., Revel M.O., Basset P. Evidence for phosphorylation of rat brain guanylate cyclase by cyclic-AMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 101:1981;1381-1387
37. Zwiller J., Revel M.O., Malviya A.N. Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J. Biol. Chem. 260:1985;1350-1353